AKT1 and hepatocellular carcinoma: The PI3K/AKT pathway assumes a pivotal role in the activation of inflammatory cells and the release of inflammatory mediators, emerging as a critical nexus in the progression of MASH or even hepatocellular carcinoma (HCC) (Becattini et al., 2021).